Dr. Rai Discusses CLL in Older Populations

Kanti R. Rai, MD
Published: Tuesday, Nov 21, 2017



Kanti R. Rai, MD, professor, The Karches Center for Oncology Research, The Feinstein Institute for Medical Research, director, Center for Oncology and Cell Biology, Long Island Jewish Medical Center, professor, Medicine and Molecular Medicine, Hofstra Northwell School of Medicine, discusses older populations with chronic lymphocytic leukemia (CLL).

Treatment should be individualized for patients with CLL, and not based solely on age, says Rai. A patient who is 65 may be as healthy as a 50-year-old, or as frail as someone much older.


Kanti R. Rai, MD, professor, The Karches Center for Oncology Research, The Feinstein Institute for Medical Research, director, Center for Oncology and Cell Biology, Long Island Jewish Medical Center, professor, Medicine and Molecular Medicine, Hofstra Northwell School of Medicine, discusses older populations with chronic lymphocytic leukemia (CLL).

Treatment should be individualized for patients with CLL, and not based solely on age, says Rai. A patient who is 65 may be as healthy as a 50-year-old, or as frail as someone much older.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x